These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38504135)

  • 21. Sharing genetic test results with family members of BRCA, PALB2, CHEK2, and ATM carriers.
    Dean M; Tezak AL; Johnson S; Pierce JK; Weidner A; Clouse K; Pal T; Cragun D
    Patient Educ Couns; 2021 Apr; 104(4):720-725. PubMed ID: 33455826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer.
    Öfverholm A; Törngren T; Rosén A; Arver B; Einbeigi Z; Haraldsson K; Ståhlbom AK; Kuchinskaya E; Lindblom A; Melin B; Paulsson-Karlsson Y; Stenmark-Askmalm M; Tham E; von Wachenfeldt A; Kvist A; Borg Å; Ehrencrona H
    BMC Cancer; 2023 Aug; 23(1):738. PubMed ID: 37563628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Only 32.3% of Breast Cancer Families with Pathogenic Variants in Cancer Genes Utilized Cascade Genetic Testing.
    Agiannitopoulos K; Potska K; Katseli A; Ntogka C; Tsaousis GN; Pepe G; Bouzarelou D; Tsoulos N; Papathanasiou A; Ziogas D; Venizelos V; Markopoulos C; Iosifidou R; Karageorgopoulou S; Giassas S; Natsiopoulos I; Papazisis K; Vasilaki-Antonatou M; Psyrri A; Koumarianou A; Matthaios D; Zairi E; Blidaru A; Banu E; Jinga DC; Laçin Ş; Özdoğan M; Papadopoulou E; Nasioulas G
    Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cascade testing for inherited arrhythmia conditions: Experiences and attitudes of family communication approaches for a Canadian cohort.
    Ho A; Leach E; Virani A; Arbour L; Bartels K; Wong EK
    J Genet Couns; 2022 Jun; 31(3):815-828. PubMed ID: 35032083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Motivation and family communication in hereditary prostate cancer genetic testing: Survey of patients from a US tertiary medical center.
    Finn CM; McCormick S; Peterson D; Niendorf KB; Rodgers LH
    J Genet Couns; 2023 Feb; 32(1):79-89. PubMed ID: 35941805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient ethnicity and cascade genetic testing: a descriptive study of a publicly funded hereditary cancer program.
    Braley EF; Bedard AC; Nuk J; Hong Q; Bedard JEJ; Sun S; Schrader KA
    Fam Cancer; 2022 Jul; 21(3):369-374. PubMed ID: 34232459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Motivating cascade testing for familial hypercholesterolemia: applying the extended parallel process model for clinician communication.
    Campbell-Salome G; Walters NL; Ladd IG; Sheldon A; Ahmed CD; Brangan A; McMinn MN; Rahm AK; Schwartz MLB; Tricou E; Fisher CL; Sturm AC
    Transl Behav Med; 2022 Jul; 12(7):800-809. PubMed ID: 35429393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From Probands to Relatives: Communication of Genetic Risk for Hereditary Breast-Ovarian Cancer and Its Influence on Subsequent Testing.
    Seven M; Shah LL; Yazici H; Daack-Hirsch S
    Cancer Nurs; 2022 Jan-Feb 01; 45(1):E91-E98. PubMed ID: 32804756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial communication and cascade testing among relatives of BRCA population screening participants.
    Lieberman S; Lahad A; Tomer A; Koka S; BenUziyahu M; Raz A; Levy-Lahad E
    Genet Med; 2018 Nov; 20(11):1446-1454. PubMed ID: 29595811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "It wasn't just for me": Motivations and implications of genetic testing for women at a low risk of hereditary breast and ovarian cancer syndrome.
    Gill G; Beard C; Storey K; Taylor S; Sexton A
    Psychooncology; 2020 Aug; 29(8):1303-1311. PubMed ID: 32497346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort.
    Sarki M; Ming C; Aissaoui S; Bürki N; Caiata-Zufferey M; Erlanger TE; Graffeo-Galbiati R; Heinimann K; Heinzelmann-Schwarz V; Monnerat C; Probst-Hensch N; Rabaglio M; Zürrer-Härdi U; Chappuis PO; Katapodi MC; On Behalf Of The Cascade Consortium
    Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Female family members lack understanding of indeterminate negative BRCA1/2 test results shared by probands.
    Himes DO; Gibbons DK; Birmingham WC; Beckstrand RL; Gammon A; Kinney AY; Clayton MF
    J Genet Couns; 2019 Oct; 28(5):950-961. PubMed ID: 31199558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigating genetic counselors' communication with Lynch syndrome patients about cascade testing: Barriers, facilitators, and strategies.
    Zhong L; Rodriguez Y; Espinel W; Ozanne EM; Kaphingst KA
    J Genet Couns; 2024 Jul; ():. PubMed ID: 38962909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; van Gool AR; Klijn JG; Tibben A
    Clin Genet; 2007 Jan; 71(1):35-42. PubMed ID: 17204044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors influencing the decision to share cancer genetic results among family members: An in-depth interview study of women in an Asian setting.
    Li ST; Sun S; Lie D; Met-Domestici M; Courtney E; Menon S; Lim GH; Ngeow J
    Psychooncology; 2018 Mar; 27(3):998-1004. PubMed ID: 29314485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new paradigm of genetic testing for hereditary breast/ovarian cancers.
    Kwong A; Chen JW; Shin VY
    Hong Kong Med J; 2016 Apr; 22(2):171-7. PubMed ID: 26980575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of targeted cascade genetic testing in the family members of BRCA1/2 gene pathogenic variant/likely pathogenic variant carriers.
    Lee J; Ham JY; Park HY; Jung JH; Kim WW; Kang B; Chae YS; Lee SJ; Lee IH; Lee NY
    Sci Rep; 2022 Feb; 12(1):1842. PubMed ID: 35115620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experience of Asian males communicating cardiac genetic risk within the family.
    Kam S; Bylstra Y; Forrest L; Macciocca I; Foo R
    J Community Genet; 2018 Jul; 9(3):293-303. PubMed ID: 29308542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and early-stage evaluation of a patient portal to enhance familial communication about hereditary cancer susceptibility testing: A patient-driven approach.
    Pollard S; Weymann D; Loewen R; Nuk J; Sun S; Schrader KA; Hessels C; Regier DA
    Health Expect; 2023 Apr; 26(2):774-784. PubMed ID: 36660874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.